Elanco Animal Health Incorporated
US ˙ NYSE ˙ US28414H1032

SecurityELAN / Elanco Animal Health Incorporated
InstitutionVan Eck Associates Corp
Latest Disclosed Ownership931,364 shares
Latest Disclosed Value $ 22,288
Van Eck Associates Corp reports 8.05% increase in ownership of ELAN / Elanco Animal Health Incorporated

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 931,364 shares of Elanco Animal Health Incorporated (US:ELAN) valued at $22,287,541 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 862,010 shares of Elanco Animal Health Incorporated. This represents a change in shares of 8.05% during the quarter. The current value of the position is $23,014,004 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Elanco Animal Health COM 28414H103 931,364 69,354 8.05 22 15.79 0.0146
2026-02-13 2025-12-31 13F Elanco Animal Health COM 28414H103 862,010 63,554 7.96 20 18.75 0.0161
2025-11-13 2025-09-30 13F Elanco Animal Health COM 28414H103 798,456 -78,736 -8.98 16 33.33 0.0149
2025-08-14 2025-06-30 13F Elanco Animal Health COM 28414H103 877,192 -556,407 -38.81 13 -20.00 0.0142
2025-05-15 2025-03-31 13F Elanco Animal Health COM 28414H103 1,433,599 488,621 51.71 15 36.36 0.0195
2025-01-29 2024-12-31 13F Elanco Animal Health COM 28414H103 944,978 36,239 3.99 11 0.00 0.0147
2024-10-29 2024-09-30 13F Elanco Animal Health COM 28414H103 908,739 -143,593 -13.65 11 -26.67 0.0142
2024-07-31 2024-06-30 13F Elanco Animal Health COM 28414H103 1,052,332 -107,479 -9.27 15 -16.67 0.0216
2024-04-30 2024-03-31 13F Elanco Animal Health COM 28414H103 1,159,811 -211,228 -15.41 19 -10.00 0.0285
2024-02-05 2023-12-31 13F Elanco Animal Health COM 28414H103 1,371,039 -249,603 -15.40 20 11.11 0.0372
2023-11-08 2023-09-30 13F Elanco Animal Health COM 28414H103 1,620,642 -89,661 -5.24 18 5.88 0.0400
2023-08-03 2023-06-30 13F Elanco Animal Health COM 28414H103 1,710,303 321,238 23.13 17 30.77 0.0377
2023-05-03 2023-03-31 13F Elanco Animal Health COM 28414H103 1,389,065 -268,476 -16.20 13 -35.00 0.0297
2023-02-08 2022-12-31 13F Elanco Animal Health COM 28414H103 1,657,541 217,344 15.09 20 -99.89 0.0523
2022-10-27 2022-09-30 13F Elanco Animal Health COM 28414H103 1,440,197 -475,506 -24.82 17,873 -52.47 0.0532
2022-08-03 2022-06-30 13F Elanco Animal Health COM 28414H103 1,915,703 541,538 39.41 37,605 4.89 0.0997
2022-05-10 2022-03-31 13F Elanco Animal Health COM 28414H103 1,374,165 292,157 27.00 35,852 16.76 0.0740
2022-01-26 2021-12-31 13F Elanco Animal Health COM 28414H103 1,082,008 83,607 8.37 30,707 -3.56 0.0710
2021-11-03 2021-09-30 13F Elanco Animal Health COM 28414H103 998,401 68,435 7.36 31,839 -1.31 0.0801
2021-08-10 2021-06-30 13F Elanco Animal Health COM 28414H103 929,966 24,052 2.65 32,261 20.92 0.0763
2021-05-13 2021-03-31 13F Elanco Animal Health COM 28414H103 905,914 381,731 72.82 26,679 65.95 0.0726
2021-02-09 2020-12-31 13F Elanco Animal Health COM 28414H103 524,183 -56,617 -9.75 16,077 -0.89 0.0468
2020-12-04 2020-09-30 13F/A-1 Elanco Animal Health COM 28414H103 580,800 -232,914 -28.62 16,222 -7.06 0.0516
2020-11-12 2020-09-30 13F Elanco Animal Health COM 28414H103 580,800 476,909 16,222 51,631.6190
2020-08-14 2020-06-30 13F/A-1 Elanco Animal Health COM 28414H103 813,714 88,360 12.18 17,454 7.47 0.0608
2020-08-10 2020-06-30 13F Elanco Animal Health COM 28414H103 813,714 707,605 17,454 60,817.6599
2020-05-12 2020-03-31 13F Elanco Animal Health COM 28414H103 725,354 51,010 7.56 16,241 -18.22 0.0825
2020-02-13 2019-12-31 13F Elanco Animal Health COM 28414H103 674,344 41,064 6.48 19,859 17.93 0.0767
2019-11-08 2019-09-30 13F Elanco Animal Health COM 28414H103 633,280 -30,632 -4.61 16,839 -24.96 0.0789
2019-08-07 2019-06-30 13F Elanco Animal Health COM 28414H103 663,912 469,050 240.71 22,440 259.10 0.1081
2019-05-13 2019-03-31 13F Elanco Animal Health COM 28414H103 194,862 -12,459 -6.01 6,249 -4.41 0.0307
2019-02-12 2018-12-31 13F Elanco Animal Health COM 28414H103 207,321 207,321 6,537 0.0328
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.